<DOC>
	<DOCNO>NCT02170571</DOCNO>
	<brief_summary>Assessment effect moderate liver impairment ( Child-Pugh classification B ) pharmacokinetics pharmacodynamics dabigatran oral administration dabigatran etexilate . Determination safety tolerability dabigatran upon administration hepatically impaired patient healthy subject ( match pair )</brief_summary>
	<brief_title>Pharmacokinetics , Pharmacodynamics , Safety Tolerability Dabigatran Etexilate Patients With Moderate Hepatic Impairment Compared Subjects With Normal Hepatic Function</brief_title>
	<detailed_description />
	<mesh_term>Hepatic Insufficiency</mesh_term>
	<mesh_term>Dabigatran</mesh_term>
	<criteria>Healthy age , weight , sexmatched subject determine result screen normal hepatic function ( group 1 ) Hepatically impaired subject determine result screen classified ChildPugh B ( group 2 ) Signed write informed consent accordance Good Clinical Practice ( GCP ) local legislation Age &gt; =18 &lt; =75 year BMI &gt; =18.0 &lt; =32 kg/m2 , least 45 kg female Creatinine clearance &gt; 80 mL/min accord Cockcroft &amp; Gault Healthy subject ( Group 1 ) meet follow criterion enter trial : Any find medical examination ( include blood pressure , pulse rate , electrocardiogram ) deviate normal clinical relevance Clinically relevant gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunologic hormonal disorder Surgery gastrointestinal tract ( except appendectomy , cholecystectomy , herniotomy ) Clinically relevant diseases central nervous system Relevant history orthostatic hypotension , faint spell blackout Evidence blood dyscrasia , haemorrhagic diathesis , severe thrombocytopenia , cerebrovascular haemorrhage , bleed tendency associate active ulceration overt bleed gastrointestinal , respiratory genitourinary tract disease condition haemorrhagic tendency ( e.g . cerebral aneurysm , dissect aorta , central nervous system ( CNS ) trauma , retinopathy , nephrolithiasis ) Recent contemplate diagnostic therapeutic procedure potential uncontrollable bleeding ( e.g . spinal puncture , lumbar block anaesthesia , surgery CNS eye surgery result large open surface ) within 14 day drug administration clinical trial Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) , deem relevant trial judge investigator For woman childbearing potential : reliable contraception ( accept method intrauterine device , hormonal contraceptive , bilateral tubal ligation , hysterectomy , condom ) pregnancy ( know detect positive pregnancy test ) breast feeding period Intake drug long halflife ( &gt; 24 hour ) ( &lt; 1 month prior administration trial ) Use drug , within 14 day prior administration trial Participation another trial investigational drug ( &lt; 2 month prior administration trial ) Drug abuse Blood donation loss &gt; 400 ml , &lt; 1 month prior administration trial Excessive physical activity &lt; 5 day prior administration study drug trial Clinically relevant laboratory abnormality Veins unsuited i.v . puncture administration prolong infusion either arm ( e.g . vein difficult locate , access puncture , vein tendency rupture puncture , etc . ) Hepatically impaired subject ( Group 2 ) meet follow criterion enter trial : Moderate severe concurrent renal function impairment ( e.g. , due hepatorenal syndrome ) Clinically relevant gastrointestinal , respiratory , cardiovascular , metabolic , immunologic hormonal disorder Surgery gastrointestinal tract ( except appendectomy , cholecystectomy , herniotomy ) Clinically relevant diseases central nervous system Relevant history orthostatic hypotension , faint spell blackout Evidence blood dyscrasia , haemorrhagic diathesis , severe thrombocytopenia , cerebrovascular haemorrhage , bleed tendency associate active ulceration overt bleed gastrointestinal , respiratory genitourinary tract disease condition haemorrhagic tendency ( e.g . cerebral aneurysm , dissect aorta , CNS trauma , retinopathy , nephrolithiasis ) consider investigator one coinvestigators clinically relevant Recent contemplate diagnostic therapeutic procedure potential uncontrollable bleeding ( e.g . spinal puncture , lumbar block anaesthesia , surgery CNS eye surgery result large open surface ) within 14 day drug administration clinical trial History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator For woman childbearing potential : reliable contraception ( accept method intrauterine device , hormonal contraceptive , bilateral tubal ligation , hysterectomy , condom ) pregnancy ( know detect positive pregnancy test ) breast feed period Use drug influence blood clot within 14 day prior administration trial Participation another trial investigational drug ( &lt; 2 month prior administration trial ) Blood donation loss &gt; 400 ml , &lt; 1 month prior administration trial Excessive physical activity &lt; 5 day prior administration study drug trial Clinically relevant laboratory abnormality ( except liver function test accord ChildPugh classification ) , constellation blood clot parameter accord judgment investigator Veins unsuited i.v . puncture administration prolong infusion either arm ( e.g . vein difficult locate , access puncture , vein tendency rupture puncture , etc . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>